Cyclin-dependent kinase inhibitor 1C (CDKN1C, also known as p57(KIP2)), a tumor suppressor, could regulate tumor cell differentiation, invasion, and angiogenesis, which is also validated as a prognostic biomarker in various cancer types, including in LIHC [35, 36]. The gene discussed is CDKN1C; the disease is cancer.